Does the systemic immune-inflammation index predict atrial fibrillation recurrence after catheter ablation in hypertensive patients?
The systemic immune-inflammation index (SII) may serve as a useful biomarker for predicting atrial fibrillation recurrence after catheter ablation in patients with hypertension.
SII is a valuable marker for predicting AF recurrence postablation in hypertensive patients. It supports inflammation-based risk assessments and should be considered in clinical risk stratification. Further research is needed to explore inflammation-targeted therapies.
Zhang et al. (Mon,) studied this question.